Bicara Therapeutics CMO Sells Shares Worth $126,000
David Raben, Chief Medical Officer of Bicara Therapeutics (NASDAQ:BCAX), sold 5,500 shares for approximately $126,000 on April 27, 2026. The transaction was part of a routine liquidity strategy and did not signal any significant change in ownership or company performance.
Tickers: $BCAX